Your browser doesn't support javascript.
loading
Optical coherence tomography in coronary atherosclerosis assessment and intervention.
Araki, Makoto; Park, Seung-Jung; Dauerman, Harold L; Uemura, Shiro; Kim, Jung-Sun; Di Mario, Carlo; Johnson, Thomas W; Guagliumi, Giulio; Kastrati, Adnan; Joner, Michael; Holm, Niels Ramsing; Alfonso, Fernando; Wijns, William; Adriaenssens, Tom; Nef, Holger; Rioufol, Gilles; Amabile, Nicolas; Souteyrand, Geraud; Meneveau, Nicolas; Gerbaud, Edouard; Opolski, Maksymilian P; Gonzalo, Nieves; Tearney, Guillermo J; Bouma, Brett; Aguirre, Aaron D; Mintz, Gary S; Stone, Gregg W; Bourantas, Christos V; Räber, Lorenz; Gili, Sebastiano; Mizuno, Kyoichi; Kimura, Shigeki; Shinke, Toshiro; Hong, Myeong-Ki; Jang, Yangsoo; Cho, Jin Man; Yan, Bryan P; Porto, Italo; Niccoli, Giampaolo; Montone, Rocco A; Thondapu, Vikas; Papafaklis, Michail I; Michalis, Lampros K; Reynolds, Harmony; Saw, Jacqueline; Libby, Peter; Weisz, Giora; Iannaccone, Mario; Gori, Tommaso; Toutouzas, Konstantinos.
Afiliação
  • Araki M; Massachusetts General Hospital, Boston, MA, USA.
  • Park SJ; Asan Medical Center, Seoul, South Korea.
  • Dauerman HL; University of Vermont, Burlington, VT, USA.
  • Uemura S; Kawasaki Medical School, Okayama, Japan.
  • Kim JS; Yonsei University College of Medicine, Seoul, South Korea.
  • Di Mario C; Careggi University Hospital, Florence, Italy.
  • Johnson TW; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Guagliumi G; Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Kastrati A; Technische Universität München and Munich Heart Alliance, Munich, Germany.
  • Joner M; German Heart Center, Munich, Germany.
  • Holm NR; Aarhus University Hospital, Skejby, Denmark.
  • Alfonso F; Hospital Universitario La Princesa, Madrid, Spain.
  • Wijns W; National University of Ireland Galway and Saolta University Healthcare Group, Galway, Ireland.
  • Adriaenssens T; University Hospitals Leuven, Leuven, Belgium.
  • Nef H; University of Giessen, Giessen, Germany.
  • Rioufol G; Hospices Civils de Lyon and Claude Bernard University, Lyon, France.
  • Amabile N; Institut Mutualiste Montsouris, Paris, France.
  • Souteyrand G; University Hospital of Clermont Ferrand, Clermont-Ferrand, France.
  • Meneveau N; University Hospital Jean Minjoz, Besançon, France.
  • Gerbaud E; University Hospital of Bordeaux, Pessac, France.
  • Opolski MP; National Institute of Cardiology, Warsaw, Poland.
  • Gonzalo N; Hospital Clinico San Carlos, IdISSC, Universidad Complutense, Madrid, Spain.
  • Tearney GJ; Massachusetts General Hospital, Boston, MA, USA.
  • Bouma B; Massachusetts General Hospital, Boston, MA, USA.
  • Aguirre AD; Massachusetts General Hospital, Boston, MA, USA.
  • Mintz GS; Cardiovascular Research Foundation, New York, NY, USA.
  • Stone GW; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bourantas CV; Barts Health NHS Trust, University College London and Queen Mary University London, London, UK.
  • Räber L; Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Gili S; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Mizuno K; Mitsukoshi Health and Welfare Foundation, Tokyo, Japan.
  • Kimura S; Yokohama Minami Kyosai Hospital, Kanagawa, Japan.
  • Shinke T; Showa University Hospital, Tokyo, Japan.
  • Hong MK; Yonsei University College of Medicine, Seoul, South Korea.
  • Jang Y; Yonsei University College of Medicine, Seoul, South Korea.
  • Cho JM; Kyung Hee University, Seoul, South Korea.
  • Yan BP; Chinese University of Hong Kong, Hong Kong, Hong Kong.
  • Porto I; University of Genoa, Genoa, Italy, San Martino Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy.
  • Niccoli G; University of Parma, Parma University Hospital, Parma, Italy.
  • Montone RA; Catholic University of the Sacred Heart, Rome, Italy.
  • Thondapu V; Massachusetts General Hospital, Boston, MA, USA.
  • Papafaklis MI; University Hospital of Ioannina, Ioannina, Greece.
  • Michalis LK; University Hospital of Ioannina, Ioannina, Greece.
  • Reynolds H; New York University Grossman School of Medicine, New York, NY, USA.
  • Saw J; Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Libby P; Brigham and Women's Hospital, Boston, MA, USA.
  • Weisz G; New York Presbyterian Hospital, Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, USA.
  • Iannaccone M; Ospedale San Giovanni Bosco, Turin, Italy.
  • Gori T; Universitäts medizin Mainz and DZHK Rhein-Main, Mainz, Germany.
  • Toutouzas K; National and Kapodistrian University of Athens, Athens, Greece.
Nat Rev Cardiol ; 19(10): 684-703, 2022 10.
Article em En | MEDLINE | ID: mdl-35449407
Since optical coherence tomography (OCT) was first performed in humans two decades ago, this imaging modality has been widely adopted in research on coronary atherosclerosis and adopted clinically for the optimization of percutaneous coronary intervention. In the past 10 years, substantial advances have been made in the understanding of in vivo vascular biology using OCT. Identification by OCT of culprit plaque pathology could potentially lead to a major shift in the management of patients with acute coronary syndromes. Detection by OCT of healed coronary plaque has been important in our understanding of the mechanisms involved in plaque destabilization and healing with the rapid progression of atherosclerosis. Accurate detection by OCT of sequelae from percutaneous coronary interventions that might be missed by angiography could improve clinical outcomes. In addition, OCT has become an essential diagnostic modality for myocardial infarction with non-obstructive coronary arteries. Insight into neoatherosclerosis from OCT could improve our understanding of the mechanisms of very late stent thrombosis. The appropriate use of OCT depends on accurate interpretation and understanding of the clinical significance of OCT findings. In this Review, we summarize the state of the art in cardiac OCT and facilitate the uniform use of this modality in coronary atherosclerosis. Contributions have been made by clinicians and investigators worldwide with extensive experience in OCT, with the aim that this document will serve as a standard reference for future research and clinical application.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Aterosclerose / Placa Aterosclerótica / Intervenção Coronária Percutânea / Infarto do Miocárdio Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Aterosclerose / Placa Aterosclerótica / Intervenção Coronária Percutânea / Infarto do Miocárdio Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article